Market revenue in 2023 | USD 23,224.7 million |
Market revenue in 2030 | USD 39,897.3 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Manufacturing |
Fastest growing segment | Research |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Manufacturing, Research |
Key market players worldwide | Catalent Inc, Pharmaceutical Product Development, AbbVie Inc, Baxter International Inc, Grifols SA Ordinary Shares - Class A, Dalton Pharma Services, Boehringer Ingelheim, Lonza Group Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical contract manufacturing and research services market will help companies and investors design strategic landscapes.
Manufacturing was the largest segment with a revenue share of 66.17% in 2023. Horizon Databook has segmented the India pharmaceutical contract manufacturing and research services market based on manufacturing, research covering the revenue growth of each sub-segment from 2018 to 2030.
India pharmaceutical contract manufacturing and research services market is rapidly growing as a result of presence of low-cost manufacturing facilities and WHO-GMP-approved production premises in the country as well as expiring drug patents.
Manufacturing cost in India is nearly 30% to 40% lower than that in the U.S. or Europe. Low manufacturing costs can be attributed to lower capital & equipment expenses, which leads to lower costs on interest.
Horizon Databook provides a detailed overview of country-level data and insights on the India pharmaceutical contract manufacturing and research services market, including forecasts for subscribers. This country databook contains high-level insights into India pharmaceutical contract manufacturing and research services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account